From Rhetoric... To Results.
The Health Economics, Actuarial Models, and Real-World Evidence Driving System-Level Scale. 

What Are Leading Health Plans Prioritizing Next?

Deploying Cost Containment & Restructuring Managed Care Portfolios.

Rising medical loss ratios (MLRs) and evolving member demands are shifting regional payer strategies. Benchmark directly alongside executive leadership from Cigna, Humana, CVS, and Elevance as they establish the definitive 2027 parameters for clinical coverage, utilization management, and closing high-cost longitudinal health gaps. 

The Regulatory Catalyst: Navigating Federal Mandates

Strengthening Women's Health Through Regulatory Science and Innovation.

Shifting regulatory expectations now directly dictate federal compliance, clinical trial cohort diversity, and coverage design. Evaluate the immediate policy updates, evidence priorities, and enforcement timelines shaping the market directly with Dr. Kaveeta Vasisht (Associate Commissioner for Women’s Health, FDA) on our main stage. 

Evaluate Emerging Models For Population Health Improvement 

From preventative health and remote monitoring to earlier intervention and data-driven care pathways, explore the approaches helping healthcare organisations reduce risk and improve long-term outcomes at scale.